Factors contributing to the overall survival in patients with hepatocellular carcinoma treated by sorafenib.
Tsukui Y, Mochizuki H, Hoshino Y, Kawakami S, Kuno T, Fukasawa Y, Iwamoto F, Hirose S, Yoshida T, Hosoda K, Suzuki Y, Hosoda K, Kojima Y, Hirose Y, Shindou K, Matsuda M, Yagawa S, Tawara A, Kobayashi M, Konishi T, Yamazaki T, Takahashi S, Fuji H, Enomoto N, Omata M.
Tsukui Y, et al. Among authors: fukasawa y.
Hepatogastroenterology. 2012 Nov-Dec;59(120):2536-9. doi: 10.5754/hge12059.
Hepatogastroenterology. 2012.
PMID: 22497953